Helicobacter pylori and extra-digestive diseases

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 9, 1999, Pages 844-850

  Tsang, Kenneth W ^a   Lam, Shiu Kum ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Helicobacter pylori; Infection; Inflammation; Seroprevalence

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOTRIENE B4; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL GROWTH; GRAM NEGATIVE INFECTION; GROWTH RETARDATION; HELICOBACTER PYLORI; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TOXIN SYNTHESIS; VASCULAR DISEASE;

EID: 0032888210     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01974.x     Document Type: Review

References (68)

1. 1 Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. M. Engl. J. Med. 1993; 328: 349-50.
2. 2 Marshall J, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-14.
3. 3 Isaacson PG, Spencer J. Is gastric lymphoma an infectious disease? Hum. Pathol. 1993; 24: 569-70.
4. 4 Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991; 325: 1127-31.
5. 5 Graham DY, Malaty HM, Evans DG, Evans Jr DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effects of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-501.
6. 6 Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: Risk factors and effect on growth. BMJ 1994; 309: 1119-23.
7. 7 Mendall MA, Goggin PM, Molineaux N et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896-7.
8. 8 Tsang KWT, Lam SK, Lam WK et al. High seroprevalence of Helicobacter pylori in active bronchiectasis. Am. J. Respir. Crit. Care Med. 1998; 158: 1047-51.
9. 9 Dytoc M, Gold B, Louie M et al. Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infect. Immun. 1093; 61: 448-56.
10. 10 Megraud F. Toxic factors of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 1994; 6 (Suppl. 1): S5-10.
11. 11 Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 1988; 26: 93-9.
12. 12 Chen XG, Correa P, Offerhaus J et al. Ultrastructure of gastric mucosa harbouring Campylobacter like organisms. Am. J. Clin. Path. 1986; 86: 575-82.
13. 13 Goodwill CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis, and peptic ulceration. J. Clin. Pathol. 1986; 39: 353-65.
14. 14 Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN. Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 1988; 94: 33-40.
15. 15 Dunn BE, Campbell GP, Perez-Perez GI, Blaser MJ. Purification and characterisation of Helicobacter pylori urease. J. Biol. Chem. 1990; 265: 9464-9.
16. 16 Marshall BJ, Barratt LJ, Prakash C, McCallum RW, Guerrant RL. Urease protects Helicobacter pylori from the bactericidal effects of acid. Gastroenterology 1990; 99: 697-702.
17. 17 Hazel SL, Evans DJ, Graham DY. Helicobacter pylori catalase. J. Gen. Microbiol. 1991; 137: 57-61.
18. 18 Sidebotham RL, Batten JJ, Karim QN, Spencer J, Baron JH. Breakdown of gastric mucus in presence of Helicobacter pylori. J. Clin. Pathol. 1991; 44: 52-7.
19. 19 Slominary BL, Bilski J, Sarosiek J et al. Campylobacter pyloridis degrades mucin and undermines gastric mucosa integrity. Biochem. Biophys. Res. Commun. 1987; 144: 307-14.
20. 20 Sarosiek J, Marshall RJ, Peura DA. Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: A method for assessment of biopsy specimens. Am. J. Gastroenterol. 1991; 86: 729-34.
21. 21 Schleimer RP, Benenati SV, Friedman B, Bochner BS. Do cytokines play a role in leukocyte recruitment and activation in the lung? Am. Rev. Respir. Dis. 1991; 143: 1169-74.
22. 22 Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264-5.
23. 23 Kelley J. Cytokines of the lung. Am. Rev. Respir. Dis. 1990; 141: 765-88.
24. 24 Elias JA, Gustilo K, Baeder W, Freundlich B. Synergistic Stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumour necrosis factor. J. Immunol. 1987; 138: 3812-16.
25. 25 Eller J, Lapa H, Silva JR, Poulter LW, Lode H, Cole PJ. Cells and cytokines in chronic bronchial infection. Ann. NY Acad. Sci. 1994; 725: 331-45.
26. 26 Amitani R, Wilson R, Rutman A et al. Effects of human neutrophil elastase and bacterial proteinases on human respiratory epithelium. Am. J. Respir. Cell Mol Biol. 1991; 4: 26-32.
27. 27 Noach LA, Bosma NB, Jansen J, Hock FJ, van Deventer SW, Tytgat GN. Mucosal tumour necrotic factor-α, interleukin-1β, and interleukin 8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol. 1994; 29: 425-9.
28. 28 Dinarello CA. Interleukin-1 and the pathogenesis of the acute phase response. N. Engl. J. Med. 1984; 311: 1413-18.
29. 29 Yamaoka Y, Kita M, Kodama T et al. Role of chemokines in gastric mucosa with Helicobacter pylori infection. Gut 1996; 39 (Suppl.): A60 (Abstract).
30. 30 Zhang QB, Nakshabendi IM, Mokhashi MS, Dawodu JB, Gemmel CG, Russel RI. Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996; 38: 841-5.
31. 31 Evans DJ, Evans DG, Takemura T et al. Characterisation of a Helicobacter pylori neutrophil activating protein. Infect. Immun. 1995; 63: 2213-20.
32. 32 Lion DC, Wagner WW, Capen RL et al. Physiological neutrophil sequestration in the lung: Visual evidence for localization in capillaries. J. Appl. Physiol. 1987; 62: 1236-43.
33. 33 Wagner S, Beil W, Nietart M et al. Anti-proliferative role of Helicobacter pylori on human gastric epithelial cells. Gut 1996; 110: A1040 (Abstract).
34. 34 Moss SF, Calam J, Agarwal B, Wang S, Holt PG. Induction of epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 408-501.
35. 35 Patel P, Mendall MA, Carrington D et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-14.
36. 36 Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart 1996; 75: 568-72.
37. 37 Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen T. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997; 314: 1317-18.
38. 38 Rathborn B, Martin D, Stephens J, Thompson JR, Samani NJ. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart 1996; 76: 308-11.
39. 39 Niemela S, Karttunen T, Korhonen T et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying lipid concentrations? Heart 1996; 75: 573-5.
40. 40 Patel P, Carrington D, Strachan DP et al. Fibrinogen: A link between chronic infection and coronary heart disease. Lancet 1994; 343: 1634-5 (Letter).
41. 41 Phull P, Gower J, Price A, Green C, Jacyna M. Alphatocopherol antioxidant levels in chronic gastritis: Correlation with mucosal neutrophil infiltration. Gut 1993; 34 (Suppl.): S34.
42. 42 Markus HS, Mendall MA. Helicobacter pylori infection: A risk factor for ischaemic cerebrovascular disease and carotid atheroma. J. Neurol. Neurosurg. Psychiatr. 1998; 64: 104-7.
43. 43 Gasbarrini A, Massari I, Serricchio M et al. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig. Dis. Sci. 1998; 43: 1641-5.
44. 44 Mitz HS, Farber SS. Demonstration of Helicobacter pylori in tracheal secretions. J. Am. Osteopath. Assoc. 1993; 93: 87-91.
45. 45 Lapa e Silva JR, Jones JAH, Noble B, Cole PJ, Poulter LW. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989; 44: 668-73.
46. 46 Tsang KWT, Ho PL, Lam WK et al. Fluticasone reduces sputum inflammatory indices in bronchiectasis. Am. J. Respir. Crit. Care Med. 1998; 158: 723-7.
47. 47 Groeneveld K, van Alphen L, Eijk PP, Visscher G, Jansen HM; Zanen HC. Endogenous and exogenous reinfections by Haemophilia influenzae in patients with chronic obstructive pulmonary disease: The effects of antibiotic treatment on persistence. J. Infect. Dis. 1990; 161: 512-17.
48. 48 Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J. Infect. Dis. 1990; 161: 626-33.
49. 49 Tsang KW, Rutman A, Kanthakumar K et al. Haemophilus influenzae infection of human respiratory mucosa in low concentrations of antibiotics. Am. Rev. Respir. Dis. 1993; 148: 201-7.
50. 50 Tsang KW, Rutman A, Tanaka E et al. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur. Respir. J. 1994; 7: 1746-53.
51. 51 Tsang KW, Hu W, Lam WK, Ip M, Lam SK. A preliminary study of gastro-oesophageal reflux in bronchiectasis. Am. J. Respir. Crit. Care Med. 1997; 155: A107 (Abstract).
52. 52 Tsang KW, Kwok E, Lam WK et al. Helicobacter pylori seroprevalence in asthma. Hong Kong Practitioner 1999; 22 (Suppl.): 32 (Abstract).
53. 53 Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am. J. Gastroenterol. 1994; 89: 1603-4.
54. 54 Wedi B, Wagner S, Werfel T, Manns MP, Kapp A. Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int. Arch. Allergy Immunol. 1998; 116: 288-94.
55. 55 Reinauer S, Megahed M, Goerz G et al. Schönlein Henoch purpura associated with Helicobacter pylori infection. J. Am. Acad. Dermatol. 1995; 33: 876-9.
56. 56 De Vita S, Ferraccioli G, Avellini C et al. Widespread clonal B cell disorders in Sjogren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma. Gastroenterology 1996; 110: 1969-74.
57. 57 Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878 (Letter).
58. 58 De Luis DA, de Vareia C, la Calle H et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J. Clin. Gastroenterol. 1998; 26: 259-63.
59. 59 Raymond J, Bergeret M, Benhamou PH, Mensah K, Dupont C. A 2-year study of Helicobacter pylori in children. J. Clin. Microbiol. 1994; 32: 461-3.
60. 60 Rosenstock SJ, Anderson LP, Bonevie O, Jorgensen T. Serum lipids, body indices, age of menarche and Helicobacter pylori infection in 1756 Danish women. Gut 1996; 39 (Suppl. 3): A62.
61. 61 Oldenburg B, Diepersloot RJ, Hoekstra JB. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig. Dis. Sci. 1996; 41: 458-61.
62. 62 Mavromichalis I, Zaramboukas T, Giala MM. Migraine of gastrointestinal origin. Eur. J. Pediatr. 1995; 154: 406-10.
63. 63 Salmela KS, Roine RP, Koivisto T, Hook-Nikanne J, Kosunen TU, Salaspuro M. Characteristics of Helicobacter pylori alcohol dehyrogenase. Gastroenterology 1993; 105: 325-30.
64. 64 Seglen PO, Reith A. Ammonia inhibition of protein degradation in isolated rat hepatocytes. Exp. Cell Res. 1976; 100: 276-80.
65. 65 Ansorg R, Rein R, Spies A, von Recklinghausen G. Cell associated haemolytic activity of Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 1993; 12: 98-104.
66. 66 Liau YH, Lopez RA, Slomiany A, Slomiary BL. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of gastric sulfomucin. Biochem. Biophys. Res. Commun. 1992; 184: 1411-17.
67. 67 Johnson AG, McDermott SJ. Lysolecithin: A factor in the pathogenesis of gastric ulceration? Gut 1974; 15: 710-13.
68. 68 Denizot Y, Sobhani I, Rambaud JC, Lewin M, Thomas Y, Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut 1990; 21: 1242-5.